| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5507 | 2021 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1379 | 2021 |
| Distinct mechanism for antidepressant activity by blockade of central substance P receptors MS Kramer, N Cutler, J Feighner, R Shrivastava, J Carman, JJ Sramek, ... Science 281 (5383), 1640-1645, 1998 | 1372 | 1998 |
| Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 YM Li, M Xu, MT Lai, Q Huang, JL Castro, J DiMuzio-Mower, T Harrison, ... Nature 405 (6787), 689-694, 2000 | 1205 | 2000 |
| L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid β-protein precursor γ-secretase activity MS Shearman, D Beher, EE Clarke, HD Lewis, T Harrison, P Hunt, ... Biochemistry 39 (30), 8698-8704, 2000 | 517 | 2000 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 508* | 2021 |
| Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial PD Monk, RJ Marsden, VJ Tear, J Brookes, TN Batten, M Mankowski, ... The Lancet Respiratory Medicine 9 (2), 196-206, 2021 | 477 | 2021 |
| Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial WW Busse, ER Bleecker, JM FitzGerald, GT Ferguson, P Barker, ... The Lancet Respiratory Medicine 7 (1), 46-59, 2019 | 299 | 2019 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 249 | 2022 |
| Pharmacological blockade or genetic deletion of substance P (NK1) receptors attenuates neonatal vocalisation in guinea-pigs and mice NMJ Rupniak, EC Carlson, T Harrison, B Oates, E Seward, S Owen, ... Neuropharmacology 39 (8), 1413-1421, 2000 | 214 | 2000 |
| Discovery and characterization of highly potent and selective allosteric USP7 inhibitors G Gavory, CR O'Dowd, MD Helm, J Flasz, E Arkoudis, A Dossang, ... Nature chemical biology 14 (2), 118-125, 2018 | 200 | 2018 |
| Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial RAS Salman, MS Dennis, PAG Sandercock, CLM Sudlow, JM Wardlaw, ... The Lancet 393 (10191), 2613-2623, 2019 | 189 | 2019 |
| Comparison of the phenotype of NK1R−/− mice with pharmacological blockade of the substance P (NK 1) receptor in assays for antidepressant and anxiolytic drugs NMJ Rupniak, EJ Carlson, JK Webb, T Harrison, RD Porsolt, S Roux, ... Behavioural pharmacology 12 (6), 497-508, 2001 | 185 | 2001 |
| Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling HD Lewis, M Leveridge, PR Strack, CD Haldon, J O'neil, H Kim, A Madin, ... Chemistry & biology 14 (2), 209-219, 2007 | 178 | 2007 |
| Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial PM Bath, P Scutt, CS Anderson, JP Appleton, E Berge, L Cala, M Dixon, ... The Lancet 393 (10175), 1009-1020, 2019 | 167 | 2019 |
| Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations T McKeever, K Mortimer, A Wilson, S Walker, C Brightling, A Skeggs, ... New England Journal of Medicine 378 (10), 902-910, 2018 | 158 | 2018 |
| The impact of oral corticosteroid use on bone mineral density and vertebral fracture LJ Walsh, SA Lewis, CA Wong, S Cooper, J Oborne, SA Cawte, ... American journal of respiratory and critical care medicine 166 (5), 691-695, 2002 | 156 | 2002 |
| Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma … TW Harrison, P Chanez, F Menzella, GW Canonica, R Louis, BG Cosio, ... The lancet respiratory medicine 9 (3), 260-274, 2021 | 148 | 2021 |
| Piperidine-ether based hNK1 antagonists 1: determination of the relative and absolute stereochemical requirements T Harrison, BJ Williams, CJ Swain, RG Ball Bioorganic & Medicinal Chemistry Letters 4 (21), 2545-2550, 1994 | 146 | 1994 |
| Quantitative measurement of changes in amyloid-β (40) in the rat brain and cerebrospinal fluid following treatment with the γ-secretase inhibitor LY-411575 [N2-[(2S)-2-(3, 5 … JD Best, MT Jay, F Otu, J Ma, A Nadin, S Ellis, HD Lewis, C Pattison, ... Journal of Pharmacology and Experimental Therapeutics 313 (2), 902-908, 2005 | 129 | 2005 |
